Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Sells Protein Profiling Biochip System to Aventis

NEW YORK, March 6 - Zyomyx today said that Aventis has agreed to buy one of its Protein Profiling Biochip systems.

The tool consists of Zyomyx's first protein profiling biochip--called the Human Cytokine Biochip--as well as the Assay 1200 automated workstation and the Scanner 100 reader and data-analysis software.

Zyomyx said Aventis will apply the Protein Profiling Biochip System and Human Cytokine Biochips to its R&D programs in inflammation.

Financial details were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.